Breaking Bias in Clinical Trials: Sabine Oertelt-Prigione and Brandon Turner Share Insights on Diversity, Sex, and Gender Representation
Flora Peyvandi posted on X:
”Tackling biases in clinical trials to ensure diverse representation and effective outcomes.”
Professor Sabine Oertelt-Prigione has been working in the field of sex and gender-sensitive research for the last 15 years. Her current work is focused on trying to understand how sex and gender-sensitive medicine can be successfully implemented in research and practice as well as methods to investigate gender in medical research.
Dr. Brandon Turner is a resident physician in the Department of Radiation Oncology at Massachusetts General Hospital and Brigham and Women’s Hospital. He has conducted and is involved in numerous studies looking to evaluate race and ethnicity reporting and representation in clinical trials.
In this interview for Nature Communications, Sabine Oertelt-Prigione, and Brandon Turner share their knowledge about the biases that can occur in clinical trials and how they can be minimized.
Read the full article here.
Latest news in the world of research featured in Hemostasis Today.
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering
-
Aug 13, 2026, 16:07Jackie Kunzler: Accelerating Innovation in Blood Processing
-
Aug 13, 2026, 16:02Pablo Corral: Is Inflammation Really a Therapeutic Target in Atherosclerosis
-
Aug 13, 2026, 15:47Breck Gamel: Why Factor V Leiden Matters
-
Aug 13, 2026, 15:25Douglas Tavares: Clinical Strategies to Reduce Blood Transfusion and Donor Reliance
-
Aug 13, 2026, 15:21Naghmeh N.: Freeze Dried Plasma Could Transform Emergency Trauma Care